<img alt="" src="https://secure.lazy8krti.com/218831.png" style="display:none;">

Infographic: Immuno-oncology: The market opportunity for PD-1/PD-L1s

Immuno-oncology is the new frontier in cancer treatment. Using the body’s own immune system to treat cancer, new therapies are producing impressive survival benefits, with reduced side effects. Of these therapies, immune checkpoint inhibitors are showing particular promise. This infographic is a snapshot of the PD-1/PD-L1 market. 

Immuno-oncology market opportunity
Immuno-oncology market opportunity

Immuno-oncology is the new frontier in cancer treatment. Using the body’s own immune system to treat cancer, new therapies are producing impressive survival benefits, with reduced side effects. Of these therapies, immune checkpoint inhibitors are showing particular promise. This infographic is a snapshot of the PD-1/PD-L1 market. 

Download the infographic

Sign up to receive Rapport

Rapport is our e-newsletter and online resource for sharing our expertise and experience in global healthcare market research.

Sign up here